STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Oculis (SIX:OCS) announced a notification dated November 18, 2025 reporting a purchase of ordinary shares by a member of the company's Board of Directors.

The notice references an attachment named notification-of-managers-transaction-lionel-carnot-november-2025, indicating the transaction involves director Lionel Carnot.

Oculis (SIX:OCS) ha annunciato una comunicazione datata 18 novembre 2025 che riporta l'acquisto di azioni ordinarie da parte di un membro del Consiglio di amministrazione dell'azienda.

La notifica fa riferimento a un allegato denominato notification-of-managers-transaction-lionel-carnot-november-2025, indicando che la transazione coinvolge l'amministratore Lionel Carnot.

Oculis (SIX:OCS) anunció una notificación con fecha 18 de noviembre de 2025 informando la compra de acciones ordinarias por parte de un miembro del Consejo de Administración de la empresa.

La nota se refiere a un adjunto llamado notification-of-managers-transaction-lionel-carnot-november-2025, indicando que la transacción involucra al director Lionel Carnot.

Oculis (SIX:OCS)2025년 11월 18일자로 된 알림을 발표했고, 회사 이사회의 한 구성원이 보통주를 매입했다는 내용을 보고합니다.

해당 공지에는 notification-of-managers-transaction-lionel-carnot-november-2025라는 첨부 파일이 언급되어 있으며, 이 거래에 이사 Lionel Carnot가 관여하고 있음을 시사합니다.

Oculis (SIX:OCS) a annoncé une notification datée du 18 novembre 2025 mentionnant l’achat d’actions ordinaires par un membre du conseil d’administration de l’entreprise.

L’avis fait référence à une pièce jointe nommée notification-of-managers-transaction-lionel-carnot-november-2025, indiquant que la transaction implique le directeur Lionel Carnot.

Oculis (SIX:OCS) gab eine Mitteilung vom 18. November 2025 bekannt, in der der Erwerb von Stammaktien durch ein Mitglied des Vorstands des Unternehmens gemeldet wird.

Der Hinweis bezieht sich auf einen Anhang mit dem Namen notification-of-managers-transaction-lionel-carnot-november-2025, der darauf hinweist, dass die Transaktion den Direktor Lionel Carnot betrifft.

Oculis (SIX:OCS) أعلنت عن إشعار بتاريخ 18 نوفمبر 2025 يُبلغ عن شراء أسهم عادية من قبل عضو في مجلس إدارة الشركة.

يشير الإشعار إلى مرفق يُسمّى notification-of-managers-transaction-lionel-carnot-november-2025، ما يشير إلى أن الصفقة تشمل المدير Lionel Carnot.

Positive
  • None.
Negative
  • None.

ZUG, Switzerland, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to the purchase of ordinary shares by a member of the Company’s Board of Directors.

Attachment


FAQ

What did Oculis (OCS) announce on November 18, 2025 regarding insider purchases?

Oculis announced a notification of a purchase of ordinary shares by a member of its Board of Directors dated November 18, 2025.

Which director is named in the Oculis managers' transaction notification on Nov 18, 2025?

The attached notification filename references Lionel Carnot, indicating the purchase involves that board member.

Does the Oculis Nov 18, 2025 notice disclose the number of shares bought (OCS)?

The brief notice does not include share quantity; it references an attachment for transaction details.

Where can investors find details of the Oculis (OCS) director purchase announced Nov 18, 2025?

Investors should consult the referenced attachment titled notification-of-managers-transaction-lionel-carnot-november-2025 for full transaction details.

Is the Nov 18, 2025 Oculis disclosure a mandatory managers' transaction notification?

Yes; the announcement is presented as a managers' transaction notification regarding a board member's share purchase.
Oculis Holding

NASDAQ:OCS

OCS Rankings

OCS Latest News

OCS Latest SEC Filings

OCS Stock Data

1.11B
48.60M
6.31%
31.25%
0.02%
Biotechnology
Healthcare
Link
Switzerland
Zug